Myocardial Fibrosis as an Early Manifestation of Hypertrophic CardiomyopathyCarolyn Y. Ho, Christine E. Seidman, Begoña López et al.|New England Journal of Medicine|2010Cited by 706
The long noncoding RNA <i>Wisper</i> controls cardiac fibrosis and remodelingRudi Micheletti, Thierry Pedrazzini, Isabelle Plaisance et al.|Science Translational Medicine|2017Cited by 333
Diltiazem Treatment for Pre-Clinical Hypertrophic Cardiomyopathy Sarcomere Mutation CarriersCarolyn Y. Ho, Christine E. Seidman, Neal K. Lakdawala et al.|JACC Heart Failure|2014Cited by 158
The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trialJohn G.F. Cleland, Theis Lange, Muhammad Javed Khan et al.|European Heart Journal|2020Cited by 143
Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart FailureJoão Pedro Ferreira, Faı̈ez Zannad, Job A.J. Verdonschot et al.|Circulation Heart Failure|2019Cited by 97